Non-inferior efficacy of non-surgical treatment to surgical treatment in patients with nonmetastatic head and neck rhabdomyosarcoma: a SEER-based study

[1]  J. Merks,et al.  Therapy and prognostic significance of regional lymph node involvement in embryonal rhabdomyosarcoma: a report from the European paediatric Soft tissue sarcoma Study Group. , 2022, European journal of cancer.

[2]  H. Mandeville,et al.  Adolescents and young adults with rhabdomyosarcoma treated in the European paediatric Soft tissue sarcoma Study Group (EpSSG) protocols: a cohort study. , 2022, The Lancet. Child & adolescent health.

[3]  F. Denoyelle,et al.  Locoregional Control and Survival in Children, Adolescents, and Young Adults With Localized Head and Neck Alveolar Rhabdomyosarcoma—The French Experience , 2022, Frontiers in Pediatrics.

[4]  Narasimhan P. Agaram.  Evolving classification of rhabdomyosarcoma , 2021, Histopathology.

[5]  F. Dekker,et al.  An introduction to inverse probability of treatment weighting in observational research , 2021, Clinical Kidney Journal.

[6]  K. McHugh,et al.  Non-parameningeal head and neck rhabdomyosarcoma in children, adolescents, and young adults: Experience of the European paediatric Soft tissue sarcoma Study Group (EpSSG) - RMS2005 study. , 2021, European journal of cancer.

[7]  C. Robson,et al.  Role of Surgery in Rhabdomyosarcoma of the Head and Neck in Children , 2020, The Laryngoscope.

[8]  Anton G. Henssen,et al.  Current and Future Treatment Strategies for Rhabdomyosarcoma , 2019, Front. Oncol..

[9]  H. Brisse,et al.  Soft tissue sarcoma in children, adolescents and young adults: Outcomes according to compliance with international initial care guidelines. , 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[10]  S. Wolden,et al.  Worse Outcomes for Head and Neck Rhabdomyosarcoma Secondary to Reduced-Dose Cyclophosphamide. , 2019, International Journal of Radiation Oncology, Biology, Physics.

[11]  S. Kuo,et al.  Prognostic Factors and Treatment Outcomes of Adult Patients With Rhabdomyosarcoma After Multimodality Treatment , 2019, AntiCancer Research.

[12]  Yunteng Wu,et al.  Radical Surgery for Head and Neck Rhabdomyosarcoma Failed Primary Chemotherapy , 2019, The Journal of craniofacial surgery.

[13]  D. Dunaway,et al.  Psychosocial well‐being of long‐term survivors of pediatric head–neck rhabdomyosarcoma , 2018, Pediatric blood & cancer.

[14]  Serena A. Lee,et al.  Rhabdomyosarcoma of the head and neck: impact of demographic and clinicopathologic factors on survival. , 2017, Oral surgery, oral medicine, oral pathology and oral radiology.

[15]  D. Bansal,et al.  Diagnosis and Management of Rhabdomyosarcoma in Children and Adolescents: ICMR Consensus Document , 2017, The Indian Journal of Pediatrics.

[16]  A. Czarnecka,et al.  Management of pediatric head and neck rhabdomyosarcoma: A case-series of 36 patients. , 2016, Oncology letters.

[17]  Ewout W. Steyerberg,et al.  FRANK E. HARRELL, Jr., Regression Modeling Strategies: With Applications, to Linear Models, Logistic and Ordinal Regression, and Survival Analysis, 2nd ed. Heidelberg: Springer. , 2016 .

[18]  James E. Helmreich.  Regression Modeling Strategies with Applications to Linear Models, Logistic and Ordinal Regression and Survival Analysis (2nd Edition) , 2016 .

[19]  S. Uppin,et al.  Lymph node metastasis of soft tissue tumors: a cytomorphologic study. , 2015 .

[20]  M. Stevens,et al.  Randomized comparison of intensified six-drug versus standard three-drug chemotherapy for high-risk nonmetastatic rhabdomyosarcoma and other chemotherapy-sensitive childhood soft tissue sarcomas: long-term results from the International Society of Pediatric Oncology MMT95 study. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  D. Giordano,et al.  The role of surgery in children with head and neck rhabdomyosarcoma and Ewing's sarcoma. , 2010, Surgical oncology.

[22]  Peter C Austin,et al.  The performance of different propensity score methods for estimating marginal hazard ratios , 2007, Statistics in medicine.

[23]  S. Uppin,et al.  Lymph Node Metastasis of Soft Tissue Tumors , 2007, Acta Cytologica.

[24]  J. Constantinidis,et al.  Rhabdomyosarcomas of the Nose and Paranasal Sinuses: Treatment Results in 15 Cases , 2005, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[25]  H. B. Marsden,et al.  Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology--SIOP Malignant Mesenchymal Tumor 89. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  D. Kraus,et al.  Intensity-modulated radiotherapy for head-and-neck rhabdomyosarcoma. , 2004, International journal of radiation oncology, biology, physics.

[27]  J. Thomas,et al.  Prognosis of Lymph Node Metastasis in Soft Tissue Sarcoma , 2004, Annals of surgical oncology.

[28]  H. Chan,et al.  Pediatric rhabdomyosarcoma of the head and neck: is there a place for surgical management? , 2000, Archives of otolaryngology--head & neck surgery.

[29]  H. B. Marsden,et al.  Classification of rhabdomyosarcomas and related sarcomas. Pathologic aspects and proposal for a new classification‐an intergroup rhabdomyosarcoma study , 1995, Cancer.

[30]  E. Wiener.  Head and neck rhabdomyosarcoma. , 1994, Seminars in pediatric surgery.

[31]  D. Firth.  Bias reduction of maximum likelihood estimates , 1993 .

[32]  I. Fleming,et al.  Management and prognosis of head and neck sarcomas. , 1989, American journal of surgery.

[33]  松山 道郎.  Rhabdomyosarcoma , 1967, Nature Reviews Disease Primers.

[34]  M. Stevens,et al.  Parameningeal rhabdomyosarcoma in pediatric age: results of a pooled analysis from North American and European cooperative groups. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.